1 Copyright © Allyn & Bacon 2004
Chapter 4
Psychopharmacology
This multimedia product and its contents are protected under copyright law. The following are prohibited by law: any public performance or display, including transmission of any image over a network, preparation of any derivative work, including the extraction, in whole or in part, of any images; any rental, lease or lending of the program.
2 Copyright © Allyn & Bacon 2004
Psychopharmacology
Psychopharmacology:• The study of the effects of drugs on the nervous
system and on behavior.
Drug effects:• The changes a drug produces in an animal’s
physiological processes and behavior.
Sites of Action:• The locations at which molecules of drugs
interact with molecules located on or in cells of the body, thus affecting some biochemical processes of these cells.
3 Copyright © Allyn & Bacon 2004
Principles of PsychopharmacologyPharmacokinetics
Pharmacokinetics:• The process by which drugs are absorbed,
distributed within the body, metabolized, and excreted.
4 Copyright © Allyn & Bacon 2004
Principles of PharmacologyRoutes of Administration
Intravenous (IV) injection:• Injection of a substance directly into a vein.
Intraperitoneal (IP) injection:• The Injection of a substance into the peritoneal
cavity-the space that surrounds the stomach, intestines, liver, and other abdominal organs.
5 Copyright © Allyn & Bacon 2004
Principles of PharmacologyRoutes of Administration
Intramuscular (IM) injection:• Injection of a substance into a muscle.
Subcutaneous (SC) injection:• Injection of a substance into the space beneath
the skin.
Oral administration:• Administration of a substance into the mouth, so
it is swallowed.
6 Copyright © Allyn & Bacon 2004
Principles of PharmacologyRoutes of Administration
Sublingual administration:• Administration of a substance by placing it
beneath the tongue.
Intrarectal administration:• Administration of a substance into the rectum.
Inhalation:• Administration of a vaporous substance into the
lungs.
7 Copyright © Allyn & Bacon 2004
Principles of PharmacologyRoutes of Administration
Topical administration:• Administration of a substance by placing itdirectly onto the skin or mucous membrane
Intracerebral administration:• Administration of a substance directly into the
brain.
Intracerebroventricular (ICV) administration:• Administration of a substance into one of the
cerebral ventricles.
8 Copyright © Allyn & Bacon 2004
Principles of PharmacologyDrug Effectiveness
Dose-response curve:• A graph of the magnitude of an effect of a drug
as a function of the amount of the drug administered.
Therapeutic index:• The ratio between the dose that produces the
desired effect in 50% of the animals and the dose that produces toxic effects in 50% of the animals.
9 Copyright © Allyn & Bacon 2004Copyright © Allyn & Bacon 2004
10 Copyright © Allyn & Bacon 2004Copyright © Allyn & Bacon 2004
11 Copyright © Allyn & Bacon 2004
Principles of PharmacologyEffects of Repeated Administration
Tolerance:• A “decrease” in the effectiveness of a drug that is
administered repeatedly.
Sensitization:• An “increase” in the effectiveness of a drug that
is administered repeatedly.
12 Copyright © Allyn & Bacon 2004
Principles of PharmacologyEffects of Repeated Administration
Withdrawal symptom:• The appearance of symptoms opposite to those
produced by a drug when the drug is administered repeatedly and then suddenly no longer taken.
13 Copyright © Allyn & Bacon 2004
Principles of PharmacologyPlacebo Effects
Placebo:• An inert substance given to an organism in lieu of
a physiologically active drug; used experimentally to control for the effects of mere administration of a drug.
14 Copyright © Allyn & Bacon 2004
Sites of Drug Action
Antagonist:• A drug that opposes or inhibits the effects of a
particular neurotransmitter on the postsynaptic cell.
Agonist:• A drug that facilitates the effects of a particular
neurotransmitter on the postsynaptic cell.
15 Copyright © Allyn & Bacon 2004
Sites of Drug ActionEffects on Receptors
Direct agonist:• A drug that binds with an activates a receptor.
Receptor blocker:• A drug that binds with a receptor but does not
activate it; prevents the natural ligand from binding with the receptor.
16 Copyright © Allyn & Bacon 2004
Sites of Drug ActionEffects on Receptors
Direct antagonist:• Synonym for a receptor blocker.
Noncompetitive binding:• Binding of a drug to a site on a receptor; does not
interfere with the binding site for the principal ligand.
17 Copyright © Allyn & Bacon 2004
Sites of Drug ActionEffects on Receptors
Indirect antagonist:• A drug that attaches to a binding site on a
receptor and interferes with the action of the receptor; does not interfere with the binding of the principal ligand.
Indirect agonist:• A drug that attaches to a binding site on a
receptor and facilitates the action of the receptor; does not interfere with the binding site of the principal ligand.
18 Copyright © Allyn & Bacon 2004Copyright © Allyn & Bacon 2004
19 Copyright © Allyn & Bacon 2004Copyright © Allyn & Bacon 2004
20 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsAcetylcholine
The first transmitter to be discovered.
The primary neurotransmitter secreted by the efferent axons of the central nervous system.
All muscular movement is accomplished by the release of acetylcholine.
Appears to be involved in regulating REM sleep, perceptual learning, and memory.
21 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsAcetylcholine
Botulinum toxin:• An acetylcholine antagonist; prevents release by
terminal buttons.
Black widow spider venom• A poison produced by the black widow spider
that triggers the release of acetylcholine.
Neostigmine:• A drug that inhibits the activity of
acetylcholinesterase.
22 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsAcetylcholine
Nicotinic receptor:• An ionotropic acetylcholine receptor that is
stimulated by nicotine and blocked by curare.
Muscarinic receptor:• A metabotropic acetylcholine receptor that is
stimulated by muscarine and blocked by atropine.
Atropine:• A drug that blocks muscarinic acetylcholine
receptors .
Curare:• A drug that blocks nicotinic acetylcholine
receptors.
23 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsMonoamines
Catecholamines• Dopamine (DA)• Norepinephrine (NE)• Epinephrine
Indolamines• Serotonin (5-HT)
24 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsMonoamines
Monoamine:• A class of amines that includes indolamines such
as serotonin and catecholamines such as dopamine, norepinephrine, and epinephrine.
Indolamines• Serotonin (5-HT)
25 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsMonoaminesDopamine
Dopamine:• A neurotransmitter; one of the catecholamine.
• Produces both excitatory and inhibitory postsynaptic potentials.
• Implicated roles in movement, attention, learning, reinforcing effects of abused drugs.
• Synthesized from tyrosine that we obtain from our diet.
26 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsMonoaminesDopamine
L-Dopa:• The levorotatory form of DOPA; the precursor of
the catecholamines; often used to treat Parkinson’s disease because of its as a dopamine agonist.
27 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsMonoaminesDopamine
Nigrostriatal system:• A system of neurons originating in the substantia
nigra and terminating in the neostriatum (caudate nucleus and putamen of the basal ganglia); appears to play a role in the control of movement.
28 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsMonoaminesDopamine
Mesolimbic system:• A system of dopaminergic neurons originating in
the ventral tegmental area and terminating in the nucleus accumbens, amygdala, and hippocampus; appears to play a role in the reinforcing effects of drugs that are commonly abused.
29 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsMonoaminesDopamine
Mesocortical system:• A system of dopaminergic neurons originating in
the ventral tegmental area and terminating in the prefrontal cortex; appears to influence formation of short-term memories, planning, and preparing strategies for problem solving.
30 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsMonoaminesDopamine
Parkinson’s Disease:• A neurological disease characterized by tremors,
rigidity of the limbs, poor balance, and difficulty in initiating movements; caused by degeneration of the nigrostriatal system; Parkinson’s disease has been treated with L-DOPA.
31 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsMonoaminesDopamine
AMPT:• A drug that blocks the activity of tyrosine
hydroxylase and thus interferes with the synthesis of the catecholamines.
Reserpine:• A drug that interferes with the storage of
monoamines in synaptic vesicles; serves as a monoamine antagonist.
32 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsMonoaminesDopamine
Apomorphine:• A drug that blocks dopamine autoreceptors at
low doses; at high doses blocks postsynaptic receptors as well.
Methylphenidate:• A drug that inhibits the reuptake of dopamine;
also known as “Ritalin”; used to treat children with attention deficit disorder.
33 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsMonoaminesDopamine
Monoamine oxidase (MAO):• A class of enzymes that destroy the
monoamines; dopamine, norepinephrine, and serotonin.
deprenyl:• A drug that blocks the activity of MAO-B; acts as
a dopamine agonist.
34 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsMonoaminesDopamine
Chlorpromazine:• A drug that reduces the symptoms of
schizophrenia by blocking dopamine D2receptors.
Clozapine:• A drug that reduces the symptoms of
schizophrenia, apparently by blocking dopamine D4 receptors.
35 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsMonoaminesNorepinephrine (NE)
Norepinephrine is synonymous with noradrenaline.
Found in neurons of the brain and the autonomic nervous system.
Almost every region of the brain receives input from noradrenergic neurons.
Implicated to play central role in vigilance or attentiveness to events in the environment.
36 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsMonoaminesNorepinephrine (NE)
Norepinephrine:• One of the catecholamines; a neurotransmitter
found in the brain and in the sympathetic division of the autonomic nervous system.
Epinephrine:• One of the catecholamies; a hormone secreted
by the adrenal medulla; serves as a neurotransmitter in the brain.
37 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsMonoaminesNorepinephrine (NE)
Fusaric acid:• A drug that inhibits the activity of the enzyme
dopamine-ß-hydroxylase and thus blocks the production of norepinephrine.
Locus coeruleus:• A dark-colored group of noradreneric cell bodies
located in the pons near the rostral end of the floor of the fourth ventricle.
38 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsMonoaminesSerotonin (5-HT)
Serotonin:• Serotonin is an indolamine neurotransmitter; also
called 5-hydroxytryptamine (5-HT); thought to play a role in the regulation of mood, the control of eating, sleep, dreaming, and arousal; also thought to be involved in the regulation of pain.
39 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsMonoaminesSerotonin (5-HT)
• PCPA:A drug that inhibits the activity of tryptophanhydroxylase and thus interferes with the synthesis of 5-HT.
40 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsMonoaminesSerotonin (5-HT)
• Fluoxetine (Prozac):A drug that inhibits the reuptake of 5-HT.
41 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsMonoaminesSerotonin (5-HT)
• Fenfluramine:A drug that stimulates the release of 5-HT; used as an appetite suppressant.
• LSD:Lysergic acid diethylamideThis drug produces distortions of visual perceptions.A drug that stimulates 5-HT2a receptors.
42 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsAmino Acids
The most common amino acid transmitters are:
• Glutamate
• Gamma-amino-butyric acid (GABA)
• Glycine
43 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsAmino AcidsGlutamate
Glutamate:• An amino acid; the most important excitatory
neurotransmitter in the brain.
NMDA:• A drug that serves as a noradrenergic and
serotonergic agonist
44 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsAmino AcidsGlutamate
NMDA receptor:• A specialized ionotropic glutamate receptor that
controls a calcium channel that is normally blocked by Mg2+ ions; has several other binding sites.
AMPA receptor:• An ionotropic glutamate receptor that controls a
sodium channel; stimulated by AMPA and blocked by CNQX; the most common glutamate receptor.
45 Copyright © Allyn & Bacon 2004Copyright © Allyn & Bacon 2004
46 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsAmino AcidsGlutamate
Kainate receptor:• An ionotropic glutamate receptor that controls a
sodium channel; stimulated by kainic acid and blocked by CNQX.
Metabotropic glutamate receptor:• A category of metabotropic receptors sensitive to
glutamate.
AP5:• A drug that blocks the glutamate binding site on
NMDA receptors
47 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsAmino AcidsGlutamate
Phencyclidine (PCP):• A drug that binds with the PCP binding site of the
NMDA receptor and serves as an indirect antagonist of glutamate.
• Behavioral symptoms include altered body image, feelings of isolation and sadness, cognitive disorganization, apathy, hostility euphoria and dreamlike states.
48 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsAmino AcidsGABA
GABA:• An amino acid; the most important inhibitory
neurotransmitter in the brain and spinal cord.
49 Copyright © Allyn & Bacon 2004Copyright © Allyn & Bacon 2004
50 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsAmino AcidsGABA
Benzodiazepine:• A category of anxiolytic drugs; an indirect agonist
for the GABAA receptor.
Anxiolytic:• An anxiety-reducing effect.
51 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsAmino AcidsGlycine
Glycine:• An amino acid; an important inhibitory
neurotransmitter in the lower brain stem and spinal cord.
Strychnine:• A direct antagonist for the glycine receptor.
52 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsPeptides
Neurons of the central nervous system release a large variety of peptides.
A neuron manufactures both the polypeptides and the enzymes that it needs to break them apart.
Synthesis takes place in the soma and they are delivered to the terminal buttons by axoplasmictransport.
Most peptides appear to serve as neuromodulators, some act as neurotransmitter.
53 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsPeptides
Endogenous opioid:• A class of peptides secreted by the brain that act
as opiates; drugs that effect opioid receptors reduce pain.
Enkephalin:• One of the endogenous opioids.
Naloxone:• A drug that blocks opioid receptors.
54 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsLipids
Cannabinoid:• A lipid; an endogneous ligand for receptors that
bind with THC, the active ingredient in marijuana.
Anandamide:• A lipid; the endogenous ligand for receptors that
bind with THC, the active ingredient of marijuana.
55 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsLipids
Adenosine:• A nucleoside; a combination of ribose and
adenine; serves as a neuromodulator in the brain.
Caffeine:• A drug that blocks adenosine receptors.
56 Copyright © Allyn & Bacon 2004
Neurotransmitters and NeuromodulatorsSoluble Gases
Nitric oxide (NO):• A gas produced by cells in the nervous system;
used as a means of communication between cells.
Top Related